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ABSTRACT
INTRODUCTION The aim of this study was to explore the impact of increasing proportions of high risk referrals on surgical margin
outcomes of a surgeon’s learning curve in robotic prostatectomy.
METHODS All patients in this study underwent robot assisted radical prostatectomy (RARP) performed by three different consul-
tant urological surgeons. Data collected included preoperative clinical stage, Gleason score and prostate specific antigen levels,
which were used to risk stratify patients according to National Institute for Health and Care Excellence criteria. Oncological clear-
ance was assessed by overall and stage specific positive margin status. Comparisons were made between each surgeon for the first
and second 50 consecutive cases.
RESULTS For the three surgeons, there was a progressive increase in the proportion of high risk cases referred accompanied by a
corresponding decline in low risk disease (p<0.001). Postoperative pathology also showed an upward trend in pT3 cases across the
three eras. There was no statistical difference in overall positive margin rates between the surgeons. The overall rates were 12%,
20% and 23% for the first 50 cases, and 32%, 36% and 21% for the second 50 cases for the three surgeons respectively.
CONCLUSIONS Our series demonstrates an upward trend in the risk profile of men referred for robotic prostatectomy over a nine-
year period. Despite this, there was minimal impact on pathological and surgical outcomes among our surgeons, who were at the
initial stages of their RARP learning curve. Our results suggest that there is no requirement for an active case selection bias against
patients with high risk disease for surgeons newly embarking on their RARP learning experience.
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Prostate cancer is the most common malignancy in men and
remains a major cause of cancer related mortality.1,2 There
is currently no official prostate screening programme in the
UK. However, studies have shown that the number of cases
diagnosed yearly in the UK is rising and this looks set to con-
tinue along a similar trend for many years to come.3
National Institute for Health and Care Excellence (NICE)
risk stratification groups for localised prostate cancer are
defined as low risk (prostate specific antigen [PSA] <10ng/
ml, Gleason score ≤6 or cT1–T2a), intermediate risk (10–
20ng/ml, Gleason 7 or cT2b) or high risk (>20ng/ml, Glea-
son 8–10 or ≥cT2c).4 A study from 2013 looking at a ten-year
trend in prostate cancer risk profile identified significant
increasing incidences of intermediate and high risk disease
in the UK.1 As a result, there is an increase in the presenta-
tion of men with prostate cancer requiring active treatment.
To date, the benefits of surgery have been shown mainly
in men with higher risk disease.5 Over the last decade, there
has been a clear shift in the management of prostate cancer
in the UK, with increasing use of surgery for younger
patients with high risk disease. This trend has also been
observed in our unit.6–8 In contrast, the proportion of men
with low risk disease having surgery appears to be on the
decline with the concurrent increase in the use of active sur-
veillance as a treatment modality.9
Traditionally, men with high risk prostate cancer were not
thought to be ideal candidates for training surgeons at the
beginning of their robot assisted radical prostatectomy
(RARP) learning curve owing to the increased chances of a
positive surgical margin (PSM). This is because men with
higher risk prostate cancer have a higher burden of disease
and worse oncological outcomes from the outset.10–12 As a
Ann R Coll Surg Engl 2018; 00: 1–4 1
ROBOTIC SURGERY
Ann R Coll Surg Engl 2018; 00: 1–4
doi 10.1308/rcsann.2018.0001
result of changes in the surgical management of prostate
cancer, urologists are now increasingly operating on
patients with higher risk disease.8
This study examined the learning curves and surgical out-
comes of three surgeons who started RARP at a single centre
over an eight-year period. In particular, the potential impact
was explored of changing referral practices on the intrao-
perative and margin outcomes of patients undergoing
robotic prostatectomy at this unit.
Methods
All patients in this study underwent RARP between 2005 and
2014 at Addenbrooke’s Hospital with one of three different
consultant urological surgeons operating. (Surgeon A com-
menced in 2005, surgeon B in 2008 and surgeon C [VJG] in
2010.) All patients were recruited into an ethically approved
study for prospective data collection.
Preoperative data collected from the prospective database
comprised baseline demographics, Gleason score, baseline
PSA and tumour stage (cT2, cT3). Operative outcomes
focused on PSMs, operating time (excluding robot setup/
docking time) and intraoperative blood loss. All pathological
outcomes (pT2, pT3a, pT3b) were reviewed in a specialist
multidisciplinary team meeting. Tumour volume (as a
percentage of the whole resected prostate) was determined
on final pathology. All surgeons underwent a modular three-
day training programme and received mentor-led training at
the console.13 Each patient’s risk profile was stratified based
on the NICE risk classification,4 and the respective surgeons’
first 50 and second 50 cases were compared for intraopera-
tive and oncological outcomes. Statistical analysis was con-
ducted using SPSS® version 16 (SPSS, Chicago, IL, US) with a
p-value of <0.05 considered statistically significant.
Results
The first 100 cases for each of the 3 surgeons were reviewed.
The 300 patients had a median age of 61.5 years (range: 39–
74 years) and a median preoperative PSA of 7ng/ml (range:
0.5–85ng/ml). The median preoperative Gleason score was
6 for surgeons A and B while for surgeon C, it was 7. The
mean prostate volumes were 53g and 51g (surgeon A), 56g
and 55g (surgeon B), and 52g and 51g (surgeon C) for the
first and last 50 cases respectively (Table 1).
There was a progressive increase in the proportion of pre-
operative high risk cases with a corresponding decline in
low risk disease in the three surgeons’ practice (Fig 1). Low
risk cases represented 55%, 33% and 25% of the patients for
surgeons A, B and C respectively. In contrast, high risk cases
Table 1 Preoperative, intraoperative and postoperative outcomes for all cases
Surgeon A Surgeon B Surgeon C
Cases 1–50 Cases 51–100 Cases 1–50 Cases 51–100 Cases 1–50 Cases 51–100
Preoperative outcomes
Mean age (range) 61.5 years (39–74 years)
Median PSA (range) 7ng/ml (0.5–8.5ng/ml)
Median preoperative
Gleason score (range)
6 (4–9) 6 (6–8) 7 (4–9)
Intraoperative outcomes
Median blood loss (range) 288ml
(30–2,250ml)
225ml
(30–1,200ml)
250ml
(30–900ml)
250ml
(20–1,250ml)
300ml
(100–700ml)
200ml
(50–800ml)
Median operating time
(range)
185 min
(127–420 min)
180 min
(77–370 min)
237 min
(151–345 min)
201 min
(132–333 min)
270 min
(192–327 min)
220 min
(180–300 min)
Postoperative outcomes
Mean prostate volume
(range)
53g (18–125g) 51g (27–103g) 56g (35–118g) 55g (24–119g) 52g (26–92g) 51g (27–78g)
Mean tumour volume
(range)*
9% (0–40%) 15% (0.5–50%) 8% (0.5–40%) 13% (1–70%) 22% (1–70%) 17% (1–70%)
Postoperative pathological
stage
pT2 37 (74%) 30 (60%) 30 (60%) 25 (50%) 23 (46%) 23 (46%)
pT3a 11 (22%) 19 (38%) 17 (34%) 21 (42%) 24 (48%) 22 (44%)
pT3b 1 (2%) 0 (0%) 2 (4%) 4 (8%) 3 (6%) 5 (10%)
PSA = prostate specific antigen
*as a percentage of prostate volume
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constituted 10%, 15% and 24% of each surgeon’s cohort
(p=0.001). This trend is reinforced when looking at the pre-
operative clinical staging for each surgeon’s first 50 cases;
there was evidence of a progressive increase in the propor-
tion of cT3 patients over the three learning curve periods
(p=0.002) (Fig 2).
Intraoperative outcomes
Blood loss and operating time reduced progressively with
increasing experience for all surgeons regardless of when
their training commenced. When comparing individual sur-
geons’ outcomes, a general improvement in intraoperative
outcomes (ie reduction in blood loss) can be seen for sur-
geons A and C between the first and last 50 cases. For
surgeon B, however, blood loss remained the same through-
out (Table 1). A reduction in console operating time was
observed for all surgeons between the first and last 50
patients. Surgeon A’s median console time improved by 5
minutes to 180 minutes, surgeon B’s improved by 27 minutes
to 210 minutes and surgeon C’s improved by 50 minutes to
220 minutes (Table 1).
Surgical margin outcomes
There was a progressive increase in the proportion of high
risk pT3a cases over the three learning curve periods
(surgeon A: 22%, surgeon B: 34%, surgeon C: 48%). A simi-
lar trend was observed when comparing the second 50 cases
for each of the surgeons. Final tumour volumes were higher
for surgeon C than for surgeons A and B, who had com-
menced their learning before 2010 (Fig 3).
The pT2 PSM rates were 10%, 13% and 12% for the first
50 cases for surgeons A, B and C respectively (p=0.79), and
16%, 12% and 8% for the second 50 cases (p=0.70). The cor-
responding rates for pT3a tumours were 9%, 35% and 36%
for the first 50 cases (p=0.22), and 53%, 57% and 30% for the
second 50 cases (p=0.21). There was also no statistical differ-
ence in overall PSM rates between the surgeons. The overall
rates were 12%, 20% and 23% for the first 50 cases, and
32%, 36% and 21% for the second 50 cases respectively
(Fig 4).
Discussion
This study reports on the first 100 RARP cases performed by
each of three surgeons in a single UK institution but at dif-
ferent stages of the evolution of a tertiary referral practice.
Our data demonstrate an increase in the proportion of pre-
operative high risk patients undergoing RARP and an associ-
ated fall in the number of patients referred with low risk
prostate cancer. Concomitantly, an overall higher proportion
was noted of pT3 disease at final pathology compared with
other series, particularly as the series evolved with time.9
Our findings further confirm a previous study that shows
that there have been significant shifts in the management of
non-metastatic prostate cancer in the last decade with low
risk disease increasingly being managed conservatively and
high risk disease treated surgically in the UK.7 The future of
RARP training will therefore need to be geared towards
familiarising surgeons with exposure to higher risk cases at
an earlier stage of their robotic training. Our study confirms
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Figure 1 Proportions of high and low risk cases for the three
surgeons
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Figure 2 Proportions of preoperative T2 and T3 cases for the three surgeons
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that this can be achieved safely and does not disadvantage
patients in terms of tumour clearance or PSM rates.
With respect to intraoperative outcomes, the mean blood
loss across the three surgeons was 252ml and the mean
operating time was 215 minutes. These results are compara-
ble with the results obtained in other published series.14,15
Consequently, structured training programmes and mentor-
ship remain paramount in maintaining high surgical stand-
ards.16 This has particular relevance for men having radical
prostatectomy in the context of minimising PSM rates.
Study limitations
There are certain limitations to this study. This was a single
centre series that focused on the first 100 cases of RARP only.
To our knowledge, however, it is the only UK study to date
that has explored the impact of a changing referral practice
on learning curve outcomes. The learning curves of sur-
geons in our institution were not compared against those in
other UK centres so our results may not be generalisable
across the nation. Furthermore, postoperative continence
rates were not specifically examined in this study although
these data have been presented previously in a separate
paper by our group.12
Conclusions
This study shows that despite an upward trend in high risk
referrals for RARP over time, there have been no adverse
margin outcomes from surgeons beginning their learning
experience at different times. Larger prospective case series
with added postoperative functional outcomes data will fur-
ther inform these findings. Nevertheless, our study suggests
that there is no need for an active case selection bias against
patients with high risk disease for surgeons newly embark-
ing on their RARP learning experience. In our opinion, this
provides strong reassurance to centres training robotic sur-
geons as well as evidence to allay patient concerns when
their operations are being undertaken by a novice robotic
surgeon.
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Figure 3 Mean tumour volumes (as a percentage of the
prostate) for the three surgeons
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Figure 4 Positive surgical margin (PSM) rates for the three
surgeons
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